1 / 8

Drug Discovery Market

Drug Discovery Market

Mayuri24
Download Presentation

Drug Discovery Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug Discovery Market Trends, Size, Share, Demands, Overview, Growth, Revenue and Forecast to 2030 sales@delvens.comwww.delvens.com

  2. Sternal Closure Systems Market – Trends Forecast Till 2030 Drug Discovery Market, By Drug Type (Small Molecule Drugs and Biologic Drugs), By Technology (High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, and Other Technologies), By End User (Pharmaceutical Companies, Contract Research Organizations (CROs), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). Request For Free Sample Report: https://www.delvens.com/get-free-sample/drug-discovery-market sales@delvens.com www.delvens.com

  3. Market Overview The drug discovery market is experiencing robust growth driven by several key factors shaping the pharmaceutical and biopharmaceutical industries globally. A primary driver is the increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which necessitates the development of novel and more effective drugs. This trend is further bolstered by the shift towards personalized medicine, where treatments are tailored to individual genetic profiles, enhancing treatment efficacy and patient outcomes. Technological advancements, particularly the integration of AI and machine learning in drug discovery, are revolutionizing the field. These technologies enable the analysis of vast datasets to identify potential drug candidates more efficiently, speeding up the discovery process. Additionally, collaborations between pharmaceutical companies and academic institutions are fostering innovation and accelerating the development of new therapies. Purchase this Report: https://www.delvens.com/checkout/drug-discovery-market sales@delvens.com www.delvens.com

  4. Key Findings The Drug Discovery Market is segmented into Product Drug Type, Technology & End-User, and Region: On the basis of Drug Type, the differentiation between small molecule drugs and biologic drugs is pivotal for driving growth in the drug discovery market. On the basis of Technology, the integration of advanced technologies such as high throughput screening, pharmacogenomics, combinatorial chemistry, nanotechnology, and others is pivotal in driving the growth of the drug discovery market. sales@delvens.com www.delvens.com

  5. Key Findings On the basis of type, the end-user segment comprising pharmaceutical companies, contract research organizations (CROs), biotechnology firms, and academic/research institutions collectively drives growth in the drug discovery market through distinct contributions. The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period. Inquire Before Buying: https://www.delvens.com/Inquire-before-buying/drug-discovery-market sales@delvens.com www.delvens.com

  6. Competitive Landscape • Pfizer Inc. • Novartis AG • Merck & Co., Inc. • Johnson & Johnson • Roche Holding AG • Sanofi • AstraZeneca plc • GlaxoSmithKline plc • Bristol-Myers Squibb Company • Eli Lilly and Company • AbbVie Inc. • Amgen Inc. • Biogen Inc. • Gilead Sciences, Inc. • Regeneron Pharmaceuticals, Inc. • Vertex Pharmaceuticals Incorporated • Takeda Pharmaceutical Company Limited • Bayer AG • Moderna, Inc. • BioNTech SE • Vertex Pharmaceuticals • Ionis Pharmaceuticals • Genentech, Inc. • Alexion Pharmaceuticals sales@delvens.com www.delvens.com

  7. Recent Developments In October 2022, Verge Genomics, a biotechnology company at the clinical stage leveraging AI and human data to revolutionize drug discovery, has initiated dosing the first participant in its Phase 1 clinical trial for VRG50635. In August 2022, NGM Bio unveiled the top-line findings from the CATALINA Phase 2 Trial of NGM621, targeting patients with geographic atrophy (GA) due to age-related macular degeneration. sales@delvens.com www.delvens.com

  8. Contact Information About Us: Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally. Contact Us: +44-20-3290-6466 +1 214-377-1144 sales@delvens.com sales@delvens.com www.delvens.com

More Related